Novel compounds FR901512 and FR901516 were isolated from the fermentation broth of agonomycete strain No. 14919. FR901512 and FR901516 possess unique tetralin ring in their structure. These compounds were potent inhibitors of the cholesterol synthesis in human hepatoma cell line Hep G2. FR901512 shows strong 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitory activity with an IC50 value of 0.95nM.
High levels of blood cholesterol and blood lipids are conditions involved in the onset of arteriosclerosis. It is well known that inhibitors of cholesterol biosynthesis such as 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors are effective in lowering the level of blood plasma cholesterol, especially low density lipoprotein cholesterol (LDL-C). It has been established that lowering LDL-C levels affords protection from arteriosclerosis and coronary artery disease1-6).
While screening microbial fermentation products for an inhibitor of sterol synthesis, we identified FR901512 (1) and FR901516 (2) (Fig. 1.) from culture broth of an agonomycetous fungus No. 14919. In this paper, we describe the cultural characteristics of the producing organism, production, purification, physico-chemical properties and in vitro biological activities of compounds 1 and 2. The morphological characteristics were determined based on cultures grown on Miura's LCA agar8). These characteristics were observed after 14 days of incubation at liters of cultured broth using essentially similar methods. After the structure elucidation, compound 2 was prepared from compound 1 using a conventional lactonization method.
Materials and Methods

Cultural
Measurement of Cholesterol Synthesis in Hep G2 Cells
Culture of Human hepatoma cell line Hep G2 was described previously10). Cholesterol synthesis in Hep G2 cells was determined according to the method of BROWN et al.11) with some modifications. In brief, Hep G2 cells were cultured 35mm dishes with 1ml of fresh medium 
Isolation
The procedure used to isolation of 1 is summarized in Figure 3 . During the isolation procedure, the pH of sample was controlled to slightly acidic condition to maintain the free acid from of compound 1. The overall yield of purification was 47%.
Physico-chemical Properties
The physico-chemical properties of compound 1 and 2 are summarized in Table 2 . The Rf value of compound 1 and 2 on silica gel TLC (silica gel 60 F254, E.
Merck) developed with chloroform:methanol:acetic acid (100:10:1, v/v) were 0.30 and 0.57, respectively. By a combination of physico-chemical and spectral evidence, the planer structure of compound 1 and 2 were elucidated (Fig  1) . Full details of the structure elucidation of these compounds will be published elsewhere. (Table 3) . These compounds did not inhibit cholesterol synthesis from mevalonic acid, which is product of HMG-CoA reductase (data not shown). Therefore the inhibition point of these compounds in cholesterol synthesis is at an earlier step than mevalonic acid formation. 14919. This strain did not sporulate at tested culture conditions. The morphological characteristics showed that strain No. 14919 was classified as a mycelia sterilia13). (Table 4) . Based on physico-chemical data and 2D-NMR spectra, these compounds have novel structure (Fig. 1) . Compounds 1 and 2 were structurally unique compared to previously reported naturally occurring HMG-CoA reductase inhibitors such as mevastatin or lovastatin6). Compounds 1 and 2 have unique tetralin nucleus instead of hexahydronaphthalene ring in mevastatin and lovastatin. And the moiety derived from 3,5-dihydroxy-heptanoic acid in the mevastatin and lovastatin was replaced by 3,5-dihydroxy-heptaenoic acid in compounds 1 and 2.
Inhibition of Sterol Synthesis in
As noted and shown in Table 4 , compound 1 inhibited HMG-CoA reductase activity with an IC50 value of 0.95nM.
While inhibitory activity for HMG-CoA reductase of 2 is less potent than 1, compound 2 was not completely hydrolyzed to acid form under the assay conditions. Compounds 1 and 2 potently inhibited cholesterol synthesis in Hep G2 cells from 14C-acetic acid with an IC50 value of 1.0 and 0.59nM, respectively (Table 3) . But compounds 1 and 2 did not inhibit the cholesterol synthesis from 14C-mevalonate in Hep G2 cells (data not shown).
These data suggests that compounds 1 or 2 inhibits HMG-CoA reductase actinity in Hep G2 cells, and would possess lipid-lowering effects in animal model or in human. We describe in our adjoining paper the in vivo hypolipidemic effects of compound 114)
